vera
TreatmentConcernAboutDownload Vera

Ellacor

Also known as: Ellacor, Ellacor System, Ellacor Micro-Coring, Ellacor Micro-Coring Technology, Cytrellis Ellacor, Ellacor Skin Resurfacing, Micro-Coring Skin Treatment, Ellacor Wrinkle Reduction System, Ellacor Dermal Micro-Coring, Ellacor Non-Thermal Resurfacing, Ellacor Aesthetic Device, Ellacor Coring Procedure, Ellacor Minimally Invasive Resurfacing, Ellacor Tissue Removal System, Ellacor Facial Tightening Treatment

Chemical Peels and Skin Rejuvenation

AI Aesthetician Summary

Ellacor represents a groundbreaking advancement in aesthetic medicine, utilizing proprietary Micro-Coring Technology to address moderate to severe facial wrinkles through a novel, non-thermal approach. This innovative system employs precision-engineered hollow needles to remove microscopic cores...

Treatment Details

Targets

Concerns:Nose-to-mouth LinesCrepey SkinBarcode Lip LinesSagging SkinSagging JawlineWrinklesMarionette Lines
Areas:Jaw, Chin, Neck, Cheek, Mouth
Tissues:Skin (Epidermis, Dermis)
Longevity:5-10 Years

How it Works

Duration:30 minutes
Anesthesia:Local Injection
Pain Level:Mild
Techniques:Microneedling
Multiple Sessions:Yes

Post Treatment

Downtime:3 days
Post-care:Follow post-procedure care instructions carefully, avoiding makeup, sunscreen, and other skincare products until the micro-core holes have closed (typically 2 days). Cleanse the treated area twice daily with a mild cleanser and pat dry, then apply a thin layer of petrolatum or physician-recommended ointment. Protect the skin from direct and prolonged sun exposure and avoid activities that cause overheating or excessive sweating for at least one week; apply ice to reduce any swelling.
Risks:Common temporary side effects: Redness (erythema, 90-100% of patients, resolves in 3-7 days); swelling (edema, 80-90%, peaks at 24-48 hours); pinpoint bleeding or bruising (70-80%, minor and self-resolving); mild crusting or scabbing (50-60%, lasts 5-7 days); temporary discomfort or itching (40-50%, managed with topicals). Rare but serious risks: Infection (e.g., bacterial or herpes reactivation, <1%); prolonged healing or delayed wound closure (<1%); hyperpigmentation or hypopigmentation (<2%, more in darker skin types); scarring or textural changes (<1%); allergic reaction to anesthesia (<0.5%).

Additional Information

Invasiveness:Minimally Invasive
Manufacturer:Cytrellis Biosystems, Inc.
Specialty:Cosmetic Surgery